Vanessa M Barnabei
Affiliation: Medical College of Wisconsin
- Menopausal symptoms in older women and the effects of treatment with hormone therapyVanessa M Barnabei
Medical College of Wisconsin, Milwaukee 53226, USA
Obstet Gynecol 100:1209-18. 2002..The frequency and severity of such symptoms and response to hormone therapy in older women have not been well documented...
- Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health InitiativeVanessa M Barnabei
Department of Obstetrics and Gynecology, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA
Obstet Gynecol 105:1063-73. 2005..To estimate the effects of estrogen plus progestin (E+P) therapy on menopausal symptoms, vaginal bleeding, gynecologic surgery rates, and treatment-related adverse effects in postmenopausal women...
- Factors associated with recurrent bacterial vaginosisTimothy E Klatt
Department of Obstetrics and Gynecology and Division of Biostatistics, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA
J Reprod Med 55:55-61. 2010....
- Is there an association between athletic amenorrhea and endothelial cell dysfunction?Anne Zeni Hoch
Sports Medicine Center, Departments of Orthopaedic Surgery Cardiovascular Center, Milwaukee, WI 53226, USA
Med Sci Sports Exerc 35:377-83. 2003..To test the hypothesis that young females with athletic amenorrhea and oligomenorrhea show signs of early cardiovascular disease manifested by decreased endothelium-dependent dilation of the brachial artery...
- The effects of a web-based tool on patient-provider communication and satisfaction with hormone therapy: a randomized evaluationVanessa M Barnabei
Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
J Womens Health (Larchmt) 17:147-58. 2008..To assess the effect of an Internet-based questionnaire used by a patient to generate customized data and questions about menopausal hormone therapy (HT) on patient-provider communication and satisfaction...
- Effects of estrogen with and without progestin on urinary incontinenceSusan L Hendrix
Department of Obstetrics and Gynecology, Wayne State University School of Medicine Hutzel Women s Hospital, Detroit, Mich 48201, USA
JAMA 293:935-48. 2005..Menopausal hormone therapy has long been credited with many benefits beyond the indications of relieving hot flashes, night sweats, and vaginal dryness, and it is often prescribed to treat urinary incontinence (UI)...
- Symptom experience after discontinuing use of estrogen plus progestinJudith K Ockene
Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester 01655, USA
JAMA 294:183-93. 2005..Little is known about women's experiences after stopping menopausal hormone therapy...
- Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopauseJacques E Rossouw
Women s Health Initiative Branch, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA
JAMA 297:1465-77. 2007..The timing of initiation of hormone therapy may influence its effect on cardiovascular disease...
- Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal womenAnne McTiernan
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Breast Cancer Res Treat 108:217-31. 2008..These results suggest that while age, oophorectomy status, and NSAID use may be associated with selected sex hormone concentrations, few menstrual or reproductive factors affect endogenous sex hormones in the postmenopausal period...
- Venous thrombosis and conjugated equine estrogen in women without a uterusJ David Curb
University of Hawaii and Pacific Health Research Institute, Honolulu, USA
Arch Intern Med 166:772-80. 2006..03), even after adjusting for VT risk factors. CONCLUSION: An early increased VT risk is associated with use of estrogen, especially within the first 2 years, but this risk increase is less than that for estrogen plus progestin...
- Association of pelvic organ prolapse and fractures in postmenopausal women: analysis of baseline data from the Women's Health Initiative Estrogen Plus Progestin trialLubna Pal
Department of Obstetrics and Gynecology and Women s Health, Albert Einstein College of Medicine, Bronx, NY, USA
Menopause 15:59-66. 2008..Testing a hypothesis that pelvic organ prolapse (POP) is a focal manifestation of disordered connective tissue, we evaluated whether there is an association between POP and history of fracture...